Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.51 USD
175.98 M USD
2.00 B USD
301.65 M
About SANTEN PHARMACEUTICAL CO
Sector
CEO
Takeshi Ito
Headquarters
Osaka
Website
Founded
2016
ISIN
JP3336000009
FIGI
BBG000DQQM00
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SNPHF is 11.37 USD — it has increased by 4.32% in the past 24 hours. Watch Santen Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Santen Pharmaceutical Co., Ltd. stocks are traded under the ticker SNPHF.
We've gathered analysts' opinions on Santen Pharmaceutical Co., Ltd. future price: according to them, SNPHF price has a max estimate of 16.63 USD and a min estimate of 10.87 USD. Watch SNPHF chart and read a more detailed Santen Pharmaceutical Co., Ltd. stock forecast: see what analysts think of Santen Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
SNPHF reached its all-time high on Mar 6, 2015 with the price of 70.12 USD, and its all-time low was 6.25 USD and was reached on Nov 8, 2022. View more price dynamics on SNPHF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SNPHF stock is 4.59% volatile and has beta coefficient of 0.31. Track Santen Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Santen Pharmaceutical Co., Ltd. there?
Today Santen Pharmaceutical Co., Ltd. has the market capitalization of 3.77 B, it has decreased by −5.94% over the last week.
Yes, you can track Santen Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Santen Pharmaceutical Co., Ltd. is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
SNPHF earnings for the last quarter are 0.16 USD per share, whereas the estimation was 0.15 USD resulting in a 7.37% surprise. The estimated earnings for the next quarter are 0.16 USD per share. See more details about Santen Pharmaceutical Co., Ltd. earnings.
Santen Pharmaceutical Co., Ltd. revenue for the last quarter amounts to 498.35 M USD, despite the estimated figure of 519.15 M USD. In the next quarter, revenue is expected to reach 481.95 M USD.
SNPHF net income for the last quarter is 56.62 M USD, while the quarter before that showed 66.05 M USD of net income which accounts for −14.28% change. Track more Santen Pharmaceutical Co., Ltd. financial stats to get the full picture.
As of Nov 16, 2024, the company has 3.74 K employees. See our rating of the largest employees — is Santen Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Santen Pharmaceutical Co., Ltd. EBITDA is 485.58 M USD, and current EBITDA margin is 23.21%. See more stats in Santen Pharmaceutical Co., Ltd. financial statements.
Like other stocks, SNPHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Santen Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Santen Pharmaceutical Co., Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Santen Pharmaceutical Co., Ltd. stock shows the neutral signal. See more of Santen Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.